Malcolm I Mitchell

Summary

Affiliation: Eli Lilly and Company
Country: USA

Publications

  1. ncbi request reprint A double-blind, randomized trial to evaluate the pharmacokinetics and tolerability of 30 or 40 mg/d oral olanzapine relative to 20 mg/d oral olanzapine in stable psychiatric subjects
    Malcolm Mitchell
    Lilly Research Centre, Eli Lilly and Co Ltd, Windlesham, Surrey, United Kingdom
    Clin Ther 28:881-92. 2006
  2. pmc Effect of exenatide on the pharmacokinetics of a combination oral contraceptive in healthy women: an open-label, randomised, crossover trial
    Prajakti A Kothare
    Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA
    BMC Clin Pharmacol 12:8. 2012
  3. pmc Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, II: investigations of mechanism
    David P McDonnell
    Lilly Research Laboratories, Indianapolis, Indiana, USA
    BMC Psychiatry 10:45. 2010

Collaborators

  • Patrizia Cavazzoni
  • Thomas Hardy
  • Prajakti A Kothare
  • David P McDonnell
  • Helle Linnebjerg
  • Justin Northrup
  • Mary E Seger
  • Kenneth Mace
  • Richard F Bergstrom
  • Holland C Detke
  • Prajakti Kothare
  • Sebastian Sorsaburu
  • Manuel V Sanchez-Felix
  • Jason Johnson
  • Mary Stickelmeyer

Detail Information

Publications3

  1. ncbi request reprint A double-blind, randomized trial to evaluate the pharmacokinetics and tolerability of 30 or 40 mg/d oral olanzapine relative to 20 mg/d oral olanzapine in stable psychiatric subjects
    Malcolm Mitchell
    Lilly Research Centre, Eli Lilly and Co Ltd, Windlesham, Surrey, United Kingdom
    Clin Ther 28:881-92. 2006
    ..Prescription monitoring in the United States suggests that oral olanzapine is prescribed in doses that exceed the approved range of 5 to 20 mg/d...
  2. pmc Effect of exenatide on the pharmacokinetics of a combination oral contraceptive in healthy women: an open-label, randomised, crossover trial
    Prajakti A Kothare
    Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA
    BMC Clin Pharmacol 12:8. 2012
    ..This study evaluated the drug interaction potential of exenatide when administered adjunctively with oral contraceptives, given their potential concomitant use...
  3. pmc Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, II: investigations of mechanism
    David P McDonnell
    Lilly Research Laboratories, Indianapolis, Indiana, USA
    BMC Psychiatry 10:45. 2010
    ..The authors conducted a series of parallel investigations into the possible reasons PDSS events occur...